The price of going regional: Raffles Medical’s S$600M bet is still struggling to pay off
- ID
- 2474
- Status
- summarized
- Published
- 02 Jul 2026, 5:45 PM
- Fetched
- 03 Jul 2026, 4:32 AM
- Provider
- Vulcan Post
- Category
- malaysia-startup
- Original URL
- https://vulcanpost.com/912086/raffles-medical-600-million-overseas-bet/
- Source URL
- https://vulcanpost.com/feed/
Summary
- Score
- 6.5
- Created
- 03 Jul 2026, 4:32 AM
- Tags
- Audience
- saas_foundersstartup_founders
What happened
Raffles Medical has spent the last decade investing S$600 million to expand beyond Singapore into regional markets, but the bet has yet to meaningfully pay off. The case highlights the difficulty of scaling healthcare operations across Southeast Asia despite the region's growing demand.
Why it matters
For Malaysian founders and operators considering regional expansion, this is a concrete cautionary tale about the cost and timeline of going regional in Southeast Asia—especially in regulated sectors like healthcare. It underscores the need to weigh capital intensity, regulatory complexity, and patient acquisition costs before committing to cross-border growth.
Discussion angle
What lessons can Malaysian startups take from Raffles Medical's struggles when planning their own regional plays—especially around timing, capital runway, and choosing the right first market beyond home turf?